| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8738673 | International Journal of Antimicrobial Agents | 2018 | 17 Pages |
Abstract
In patients receiving combination therapy for CR-KP BSI, the use of HD carbapenem seems to be associated with better outcome, even in the presence of high-level carbapenem resistance.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Maddalena Giannella, Enrico Maria Trecarichi, Daniele Roberto Giacobbe, Francesco Giuseppe De Rosa, Matteo Bassetti, Alessandro Bartoloni, Michele Bartoletti, Angela Raffaella Losito, Valerio del Bono, Silvia Corcione, Sara Tedeschi, Francesca Raffaelli,